FdaApplication

NDA 204734

Back to search

Identifiers

Properties

PropertyValue
applicant_nameTAKEDA PHARMACEUTICALS USA INC
application_typeNDA
approval_date2014-09-24

Products (2)

ProductActive ingredientStrengthDosage form
FOSRENOLLANTHANUM CARBONATEEQ 750MG BASEPOWDER;ORAL
FOSRENOLLANTHANUM CARBONATEEQ 1GM BASEPOWDER;ORAL

2 products